Sue Siegel is a GE Corporate Officer and the CEO of healthymagination. Siegel is a 25-year industry leader with corporate and venture capital experience in growing companies that bring key enabling technologies to the forefront of biomedical research and healthcare.
Prior to joining GE, Siegel was a general partner at Mohr Davidow Ventures where she led investments spanning enabling technology platforms, molecular diagnostics and digital health, which leveraged the convergence of these disciplines in driving personalized, consumer-driven and information-based healthcare. Prior to joining Mohr Davidow Ventures, Siegel served as President and Director of Affymetrix, Inc., a publicly traded company that pioneered GeneChip technology, which propelled the expansion of the genomics field and accelerated the early development of personalized medicine. During her tenure, Siegel grew the company from an early stage company into a global leader with a multi-billion dollar market cap an...
Sue Siegel, CEO of GE's healthymagination unit, offers sound advice from her experiences commercializing new technologies and innovations in the fields of biomedicine and healthcare. Siegel also explains how innovation is created in organizations of all sizes, how values impact the quality of team performance, and ways for evaluating career decisions.